Latest Pancreatic duct Stories

Dozens of therapies have been tried, but study led by University of Michigan physicians is first to show effective prevention of post-ERCP pancreatitis A study in the current issue of the New England Journal of Medicine shows a serious complication of ERCP, a procedure commonly used to diagnose and treat problems of the bile and pancreatic ducts, may be eliminated with a single dose medication. The finding is significant in helping patients avoid a condition known as post-ERCP...

WALTHAM, Mass., May 27 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) announced today that the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved the Company's proposal to re-analyze the images from our Phase 3 study to establish the utility of RG1068, synthetic human secretin, in improving magnetic resonance imaging (MRI) of the pancreas (Phase 3 re-read). The FDA and EMA have agreed to the Phase 3 re-read based on the numerous...

A recent case report published on May 14, 2010 in World Journal of Gastroenterology describes the imaging features of a ruptured superior mesenteric artery aneurysm, which created a giant hematoma and mimicked a pancreatic mass, with mild dilatation of main pancreatic duct.Previous studies have shown how pancreatic disease can be simulated by various anatomical structures in the retroperitoneal region at the pancreatic level. Aneurysm of the hepatic artery, for example, simulates pancreatic...

WALTHAM, Mass., Dec. 9 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) reported today top-line results from a Phase 3 clinical trial to evaluate the safety and efficacy of RG1068, synthetic human secretin, to improve magnetic resonance imaging (MRI) of the pancreas in patients with a history of pancreatitis. The study's co-primary endpoints were improvements in sensitivity of detection of structural abnormalities of the pancreatic ducts using RG1068 in combination with MRI...

By Kim, Tad Grobmyer, Stephen R; Dixon, Lisa R; Hochwald, Steven N We present an interesting case of a 62-year-old woman with a 3- month history of vague, left-sided abdominal pain. CT imaging revealed a hypodense lesion in the tail of the pancreas. The patient had no history of pancreatitis or autoimmune diseases. Laboratory testing revealed a normal CA19-9 (33 U/mL) and an elevated IgG4 (133 mg/dL). Due to concerns of pancreatic malignancy, she underwent operation. We found a dense,...